1. Home
  2. SPRC

SPRC

SciSparc Ltd.

Logo SciSparc Ltd.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company operates in the single segment of the Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority.

Founded: 2004 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 4.7M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 1.3M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -14.43 EPS Growth: N/A
52 Week Low/High: $1.58 - $23.66 Next Earning Date: 05-28-2024
Revenue: $2,879,000 Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: